Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 22 crawled time : 01:00 save search
Bluerock Total Income+ Real Estate Fund Announces 36th Consecutive Quarterly Distribution at a 5.25% Annualized Rate
Published: 2021-12-22 (Crawled : 01:00) - prnewswire.com
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: 0.72%
H: 0.97%
C: 0.33%
distribution
Novartis Cosentyx® receives FDA approval for the treatment of children and adolescents with enthesitis-related arthritis and psoriatic arthritis
Published: 2021-12-22 (Crawled : 01:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.23%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.56%
H: 0.43%
C: -0.15%
cosentyx novartis treatment fda fda approval approval children
Bright Scholar Announces Unaudited Financial Results for the Fourth Fiscal Quarter and Fiscal Year 2021
Published: 2021-12-22 (Crawled : 01:00) - prnewswire.com
BEDU | News | $2.01 6.92% -4.98% 18K
|
Commercial Services
|
| O: -6.83%
H: 16.67%
C: 15.33%
financial results results
Ellume Insights: How to Choose the Right At-Home COVID Test
Published: 2021-12-22 (Crawled : 01:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 0.39%
H: 2.32%
C: -0.13%
covid covid test test
AppTech Payments Corp. Welcomes Software Veteran, Aram Aghapour, as Senior Vice President of Research, Development & Infrastructure Operations
Published: 2021-12-22 (Crawled : 01:00) - globenewswire.com
APCX | $0.9155 -5.62% -5.95% 89K
|
Information
|
| O: 0.0%
H: 10.0%
C: 3.0%
research software
Coro Global Inc. Expects to Return to Operations in 2022
Published: 2021-12-22 (Crawled : 01:00) - globenewswire.com
CGLO | $0.0005 119900.0% 500
|
Information
| Email alert
Add to watchlist
Allakos Announces Topline Phase 3 Data from the ENIGMA 2 Study and Phase 2/3 Data from the KRYPTOS Study in Patients with Eosinophilic Gastrointestinal Diseases
Published: 2021-12-22 (Crawled : 01:00) - globenewswire.com
ALLK | $1.065 0.47% 0.47% 420K
|
Health Technology
|
| O: -87.46%
H: 2.55%
C: -19.19%
phase 2 phase 2/3 gastrointestinal disease test topline phase 3
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.